Collaboration agreement with AbbVie - Narrative (Details) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Collaboration revenue		$ 4,015,000	$ 2,364,000	$ 6,941,000	$ 3,393,000
Deferred revenue		0		0
Collaboration agreement with AbbVie
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Upfront payment	$ 30,000,000
Performance obligation	$ 30,000,000
Collaboration revenue		$ 4,000,000	$ 2,400,000	$ 6,941,000	$ 3,400,000